134 related articles for article (PubMed ID: 19848584)
1. Efficient inhibition of hepatitis B virus replication in vivo, using polyethylene glycol-modified adenovirus vectors.
Crowther C; Ely A; Hornby J; Mufamadi S; Salazar F; Marion P; Arbuthnot P
Hum Gene Ther; 2008 Nov; 19(11):1325-31. PubMed ID: 19848584
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of HBV replication in vivo using helper-dependent adenovirus vectors to deliver antiviral RNA interference expression cassettes.
Crowther C; Mowa MB; Ely A; Arbuthnot PB
Antivir Ther; 2014; 19(4):363-73. PubMed ID: 24296696
[TBL] [Abstract][Full Text] [Related]
3. Efficient silencing of hepatitis B virus by helper-dependent adenovirus vector-mediated delivery of artificial antiviral primary micro RNAs.
Mowa MB; Crowther C; Ely A; Arbuthnot P
Microrna; 2012; 1(1):19-25. PubMed ID: 25048086
[TBL] [Abstract][Full Text] [Related]
4. Suppression of hepatitis B virus antigen production and replication by wild-type HBV dependently replicating HBV shRNA vectors in vitro and in vivo.
Li B; Sun S; Li M; Cheng X; Li H; Kang F; Kang J; Dörnbrack K; Nassal M; Sun D
Antiviral Res; 2016 Oct; 134():117-129. PubMed ID: 27591142
[TBL] [Abstract][Full Text] [Related]
5. Controlling HBV replication in vivo by intravenous administration of triggered PEGylated siRNA-nanoparticles.
Carmona S; Jorgensen MR; Kolli S; Crowther C; Salazar FH; Marion PL; Fujino M; Natori Y; Thanou M; Arbuthnot P; Miller AD
Mol Pharm; 2009; 6(3):706-17. PubMed ID: 19159285
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of hepatitis B virus replication by helper dependent adenoviral vectors expressing artificial anti-HBV pri-miRs from a liver-specific promoter.
Mowa MB; Crowther C; Ely A; Arbuthnot P
Biomed Res Int; 2014; 2014():718743. PubMed ID: 25003129
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of multiple gene expression and virus replication of HBV by stable RNA interference in 2.2.15 cells.
Ren X; Luo G; Xie Z; Zhou L; Kong X; Xu A
J Hepatol; 2006 Apr; 44(4):663-70. PubMed ID: 16466826
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus Vector Harboring the HBcAg and Tripeptidyl Peptidase II Genes Induces Potent Cellular Immune Responses In Vivo.
Tan Q; Ma S; Hu J; Chen X; Yu Y; Tang Z; Zang G
Cell Physiol Biochem; 2017; 41(2):423-438. PubMed ID: 28214886
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of replication of hepatitis B virus in transgenic mice following administration of hepatotropic lipoplexes containing guanidinopropyl-modified siRNAs.
Marimani MD; Ely A; Buff MC; Bernhardt S; Engels JW; Scherman D; Escriou V; Arbuthnot P
J Control Release; 2015 Jul; 209():198-206. PubMed ID: 25937322
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus inhibition in mice by lentiviral vector mediated short hairpin RNA.
Deng L; Li G; Xi L; Yin A; Gao Y; You W; Wang X; Sun B
BMC Gastroenterol; 2009 Oct; 9():73. PubMed ID: 19804649
[TBL] [Abstract][Full Text] [Related]
11. Adenoviral delivery of recombinant hepatitis B virus expressing foreign antigenic epitopes for immunotherapy of persistent viral infection.
Wang Z; Zhu K; Bai W; Jia B; Hu H; Zhou D; Zhang X; Zhang X; Xie Y; Bourgine MM; Michel ML; Lan K; Deng Q
J Virol; 2014 Mar; 88(5):3004-15. PubMed ID: 24371056
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses.
Mok H; Palmer DJ; Ng P; Barry MA
Mol Ther; 2005 Jan; 11(1):66-79. PubMed ID: 15585407
[TBL] [Abstract][Full Text] [Related]
13. Sustained inhibition of hepatitis B virus replication in vivo using RNAi-activating lentiviruses.
Ivacik D; Ely A; Ferry N; Arbuthnot P
Gene Ther; 2015 Feb; 22(2):163-71. PubMed ID: 25338920
[TBL] [Abstract][Full Text] [Related]
14. Use of RNA interference to modulate liver adenoma development in a murine model transgenic for hepatitis B virus.
Chen CC; Chang CM; Sun CP; Yu CP; Wu PY; Jeng KS; Hu CP; Chen PJ; Wu JC; Shih CH; Gershwin ME; Tao MH
Gene Ther; 2012 Jan; 19(1):25-33. PubMed ID: 21562593
[TBL] [Abstract][Full Text] [Related]
15. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
Sun Y; Li Z; Li L; Li J; Liu X; Li W
Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
[TBL] [Abstract][Full Text] [Related]
16. Effective tumor targeted gene transfer using PEGylated adenovirus vector via systemic administration.
Gao JQ; Eto Y; Yoshioka Y; Sekiguchi F; Kurachi S; Morishige T; Yao X; Watanabe H; Asavatanabodee R; Sakurai F; Mizuguchi H; Okada Y; Mukai Y; Tsutsumi Y; Mayumi T; Okada N; Nakagawa S
J Control Release; 2007 Sep; 122(1):102-10. PubMed ID: 17628160
[TBL] [Abstract][Full Text] [Related]
17. Long-term inhibition of hepatitis B virus in transgenic mice by double-stranded adeno-associated virus 8-delivered short hairpin RNA.
Chen CC; Ko TM; Ma HI; Wu HL; Xiao X; Li J; Chang CM; Wu PY; Chen CH; Han JM; Yu CP; Jeng KS; Hu CP; Tao MH
Gene Ther; 2007 Jan; 14(1):11-9. PubMed ID: 16929350
[TBL] [Abstract][Full Text] [Related]
18. Stable inhibition of hepatitis B virus proteins by small interfering RNA expressed from viral vectors.
Moore MD; McGarvey MJ; Russell RA; Cullen BR; McClure MO
J Gene Med; 2005 Jul; 7(7):918-25. PubMed ID: 15756649
[TBL] [Abstract][Full Text] [Related]
19. Exploring gene-deleted adenoviral vectors for delivery of short hairpin RNAs and reduction of hepatitis B virus infection in mice.
Rauschhuber C; Xu H; Salazar FH; Marion PL; Ehrhardt A
J Gene Med; 2008 Aug; 10(8):878-89. PubMed ID: 18470951
[TBL] [Abstract][Full Text] [Related]
20. In Vivo Modelling of Hepatitis B Virus Subgenotype A1 Replication Using Adeno-Associated Viral Vectors.
Limani SW; Mnyandu N; Ely A; Wadee R; Kramvis A; Arbuthnot P; Maepa MB
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
